Compare · GNMK vs MDLN
GNMK vs MDLN
Side-by-side comparison of GenMark Diagnostics, Inc. (GNMK) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GNMK and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $50.91B.
- MDLN has hit the wire 4 times in the past 4 weeks while GNMK has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for GNMK).
- Company
- GenMark Diagnostics, Inc.
- Medline Inc.
- Price
- -
- $38.78+3.02%
- Market cap
- -
- $50.91B
- 1M return
- -
- +7.57%
- 1Y return
- -
- -4.83%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2010
- 2025
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 25
Latest GNMK
- Gene Panel Market size worth $ 8.22 Million, Globally, by 2028 at 21.36% CAGR: Verified Market Research®
- SEC Form SC 13G/A filed by GenMark Diagnostics, Inc. (Amendment)
- SEC Form 15-12B filed by GenMark Diagnostics, Inc.
- SEC Form EFFECT filed by GenMark Diagnostics, Inc.
- SEC Form S-8 POS filed by GenMark Diagnostics, Inc.
- SEC Form S-8 POS filed by GenMark Diagnostics, Inc.
- SEC Form S-8 POS filed by GenMark Diagnostics, Inc.
- SEC Form S-8 POS filed by GenMark Diagnostics, Inc.
- SEC Form S-8 POS filed by GenMark Diagnostics, Inc.
- SEC Form S-8 POS filed by GenMark Diagnostics, Inc.
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)